Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-09-24 00:00:00 ET · period of report 2025-09-23 · accession 0001789617-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-24 | 2025-09-23 | TVTX | Heerma Peter | Chief COMMERCIAL Off | G - Gift | $0.00 | -891 | 127.3K | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-23 | G | D | 891 | $0.00 | 127,324 | D | — | — |